PT892790E - Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas) - Google Patents

Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas)

Info

Publication number
PT892790E
PT892790E PT96928398T PT96928398T PT892790E PT 892790 E PT892790 E PT 892790E PT 96928398 T PT96928398 T PT 96928398T PT 96928398 T PT96928398 T PT 96928398T PT 892790 E PT892790 E PT 892790E
Authority
PT
Portugal
Prior art keywords
group
pct
substituted
methoxy
quinazolines
Prior art date
Application number
PT96928398T
Other languages
English (en)
Inventor
Luigi Angelo Rovati
Lucio Claudio Rovati
Francesco Makovec
Walter Peris
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of PT892790E publication Critical patent/PT892790E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT96928398T 1996-04-10 1996-07-31 Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas) PT892790E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96TO000275A IT1286302B1 (it) 1996-04-10 1996-04-10 Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso

Publications (1)

Publication Number Publication Date
PT892790E true PT892790E (pt) 2004-06-30

Family

ID=11414541

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96928398T PT892790E (pt) 1996-04-10 1996-07-31 Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas)

Country Status (11)

Country Link
US (1) US5985885A (pt)
EP (1) EP0892790B1 (pt)
JP (1) JP3987113B2 (pt)
AT (1) ATE264312T1 (pt)
AU (1) AU6788596A (pt)
CA (1) CA2251308A1 (pt)
DE (1) DE69632206T2 (pt)
ES (1) ES2216057T3 (pt)
IT (1) IT1286302B1 (pt)
PT (1) PT892790E (pt)
WO (1) WO1997037979A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9556148B2 (en) 2013-08-07 2017-01-31 Cadila Healthcare Limited N-cyanomethylamides as inhibitors of janus kinase
WO2016040081A1 (en) * 2014-09-09 2016-03-17 Janssen Pharmaceutica Nv Quinazoline derivatives useful as cb-1 inverse agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US4287341A (en) * 1979-11-01 1981-09-01 Pfizer Inc. Alkoxy-substituted-6-chloro-quinazoline-2,4-diones
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
IT1270993B (it) * 1994-03-18 1997-05-26 Recordati Chem Pharm Derivati chinzolilamminici attivi come alfa-antagonisti

Also Published As

Publication number Publication date
JP2000508297A (ja) 2000-07-04
JP3987113B2 (ja) 2007-10-03
CA2251308A1 (en) 1997-10-16
ITTO960275A0 (pt) 1996-04-10
US5985885A (en) 1999-11-16
AU6788596A (en) 1997-10-29
EP0892790B1 (en) 2004-04-14
DE69632206D1 (de) 2004-05-19
WO1997037979A1 (en) 1997-10-16
IT1286302B1 (it) 1998-07-08
EP0892790A1 (en) 1999-01-27
ATE264312T1 (de) 2004-04-15
DE69632206T2 (de) 2005-04-28
ES2216057T3 (es) 2004-10-16
ITTO960275A1 (it) 1997-10-10

Similar Documents

Publication Publication Date Title
Rao et al. MMP‐1 and MMP‐9 regulate epidermal growth factor‐dependent collagen loss in human carotid plaque smooth muscle cells
LU92824I2 (fr) Ceritinib ou un sel pharmaceutiquement acceptable de celui-ci
NO984084L (no) 4-Amino-pyrimidin-derivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte ved fremstilling derav
DE50302975D1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
BR0113120A (pt) Composto ou sal, composição farmacêutica, método para alterar a atividade transdutora de sinal de receptores gabaa, método para o tratamento de ansiedade, depressão, um distúrbio do sono, ou demência de alzheimer, método para demonstrar a presença de receptores de gabaa em amostras de célula ou tecido, embalagem, e, uso de um composto ou sal
ATE538090T1 (de) Verfahren zur herstellung von 2-iminopyrrolidin- derivaten
MY128370A (en) Pyrrolotriazane inhibitors of kinases
WO2004001059A3 (en) Heterocyclic inhibitors of kinases
EA200300671A1 (ru) Производные хиназолина, содержащие эти соединения лекарственные средства, их применение и способ их получения
AR008853A1 (es) Nuevos compuestos farmaceuticamente activos, su uso en la fabricacion de medicamentos, metodo de tratamiento, composicion farmaceutica, compuestosintermediarios y proceso para la fabricacion de dichos compuestos
YU65801A (sh) Biciklična heterociklična jedinjenja, farmaceutske kompozicije koje sadrže ova jedinjenja i postupci za njihovo pripremanje
ATE260910T1 (de) 4-heteroaryl-tetrahydrochinoline und ihre verwendung als inhibitoren des cholesterin-ester- transfer-proteins (ctep)
DK0959072T3 (da) Sulfonamidderivat og fremgangsmåde til fremstilling deraf
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
BRPI0407841A (pt) inibidores heterocìclicos de quinase
NO980178L (no) Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater
AU700932B2 (en) Pharmaceutical agents for the treatment of Alzheimer's disease
PT892790E (pt) Um metodo para a preparacao e uso farmaceutico de novos derivados de quinazolinas-4-amino-2-(piperidina-1-ilo-4-substituidas)
ATE254122T1 (de) Indolderivate als 5-ht1b und 5-ht1d agonisten
BRPI0507802A (pt) composto, composição, e, método para tratar inflamação ou um distúrbio metabólico
FR2738569B1 (fr) Nouveaux derives naphtamide de 3 beta-amino azabicyclo octane ou nonane, leur procede de preparation, leur utilisation a titre de medicament antipsychotique
NO974945L (no) Substituerte fenylamidiner, legemidler som inneholder disse forbindelser, samt fremgangsmåte for fremstilling av disse
ATE278667T1 (de) Tetramsäure-derivate zur verwendung in medizin und lebensmitteltechnologie
CA2485739A1 (en) Process for preparing 1-(6-methylpyridin-3-yl)-2-[(4-(methylsulphonyl)phenyl]ethanone